RNAi Technology Market Share & Trends Analysis Report By Form, By Application, By Region And Segment Forecasts 2024-2031 | Alnylam Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Atalanta Therapeutics

Global RNAi Technology Market reached US$ 1.6 billion in 2022 and is expected to reach US$ 3.6 billion by 2031 growing with a CAGR of 10.3% during the forecast period 2024-2031.

DataM Intelligence has published a new research report on "RNAi Technology Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/rnai-technology-market

RNAi Technology (RNA interference technology) is a biological process used to silence specific gene expression through the introduction of double-stranded RNA (dsRNA) into a cell. This dsRNA triggers a cellular mechanism that degrades complementary messenger RNA (mRNA) molecules, preventing the translation of the targeted gene into protein. RNAi is a powerful tool for research and therapeutic applications, enabling the study of gene function, the development of gene therapies, and the treatment of various diseases, including cancer and genetic disorders, by selectively inhibiting disease-causing genes.

Key Developments:

On May 18, 2023, Phio Pharmaceuticals Corp., a biotechnology company in the development stage with a proprietary INTASYL RNAi platform, announced pre-clinical data demonstrating that using INTASYL to silence CBL-B and TIGIT can enhance the anti-tumor response of natural killer (NK) cells, leading to more effective cell therapy for cancer treatment.

On April 26, 2023, Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. reported promising preliminary results from the ongoing single ascending dose phase of the ALN-APP Phase 1 study. This investigational RNAi therapy, known as Aln-APP, targets amyloid precursor protein (APP) and is being developed for the treatment of cerebral amyloid angiopathy (CAA) and Alzheimer's disease.

On January 5, 2023, Orbit Identification Limited, a leader in identifying therapeutic peptide hits, entered into a master service agreement with SanegeneBio Inc. (Sanegene), a start-up focused on developing new RNAi-based therapies. The collaboration aims to discover effective delivery methods for various RNA therapies to target specific tissues and effectively silence disease-causing genes.

Research Process:

Both primary and secondary data sources have been used in the global RNAi Technology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

List of the Key Players in the RNAi Technology Market:

Alnylam Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Atalanta Therapeutics, Phio Pharmaceuticals, Benitec Biopharma, Novartis AG, AstraZeneca, Silence Therapeutics, Arbutus Biopharma and Sylentis S.A

Segment Covered in the RNAi Technology Market:

By Application: Drug discovery and Development, Therapeutics, Drug Delivery, Agriculture, Others

By Type: Micro RNA, Small interfering RNA

By End User: Research and Academic Laboratories, Diagnostic Laboratories

Regional Analysis:

The global RNAi Technology Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/rnai-technology-market

Regional Analysis:

The global RNAi Technology Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The RNAi Technology Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of RNAi Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of RNAi Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/rnai-technology-market

Frequently Asked Questions

Q1) How Big is the RNAi Technology Market?

A) Global RNAi Technology Market reached US$ 1.6 billion in 2022 and is expected to reach US$ 3.6 billion by 2031 growing with a CAGR of 10.3% during the forecast period 2024-2031.

Q2) Who are the key players of RNAi Technology Market?

A) The major global players in the RNAi technology market include Alnylam Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Atalanta Therapeutics, Phio Pharmaceuticals, Benitec Biopharma, Novartis AG, AstraZeneca, Silence Therapeutics, Arbutus Biopharma and Sylentis S.A. among others.

Q3) What are the regions covered in this report?

A) The global RNAi Technology Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa

4) What are the Segments Coverd in this report?

A) The RNAi Technology market is segmented as Type, Diagnosis, Drug Class, Treatment Type, Sales Channel

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.